Old Web
English
Sign In
Acemap
>
authorDetail
>
David Henley
David Henley
Janssen Pharmaceutica
Placebo
Internal medicine
Biomarker (medicine)
Diabetes mellitus
Psychiatry
2
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study
2020
Alzheimer's Research & Therapy
Gerald Novak
Johannes Streffer
Maarten Timmers
David Henley
H. Robert Brashear
Jennifer Bogert
Alberto Russu
Luc Janssens
Ina Tesseur
Luc Tritsmans
Luc Van Nueten
Sebastiaan Engelborghs
Show All
Source
Cite
Save
Citations (23)
FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER’S DISEASE
2019
Alzheimers & Dementia
David Henley
Reisa A. Sperling
Paul S. Aisen
Rema Raman
Michael C. Donohue
Karin Ernstrom
Yingqi Shi
Keith Karcher
Nandini Raghavan
Yevgen Tymofyeyev
Robert H. Brashear
Gerald Novak
John Thipphawong
Ziad Saad
Hartmuth C. Kolb
Gary Romano
Show All
Source
Cite
Save
Citations (1)
1